CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...
Phase 1, Phase 2
St Louis, Missouri, United States and 14 other locations
pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...
Phase 1
St Louis, Missouri, United States and 34 other locations
ANDROMEDA is a first-in-human, Phase I/II, open-label, multicenter study of AZD9750 in participants with metastatic prostate cancer...
Phase 1, Phase 2
St Louis, Missouri, United States and 8 other locations
This is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate...
Phase 1
St Louis, Missouri, United States and 11 other locations
The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer...
Phase 3
St Louis, Missouri, United States and 26 other locations
The primary objectives of this study are to evaluate the safety and tolerability of xaluritamig administered as monotherapy or in combination with an...
Phase 1
St Louis, Missouri, United States and 7 other locations
The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...
Phase 4
St Louis, Missouri, United States and 13 other locations
Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...
Phase 3
St Louis, Missouri, United States and 42 other locations
This trial is a prospective clinical trial designed to demonstrate the safety and feasibility of whole-pelvis adaptive prostate stereotactic...
St Louis, Missouri, United States
period of time (for a maximum of 2 years (32 cycles) or until radiographic progression) on the treatment of castrate-resistant, metastatic prostate...
Phase 2
St Louis, Missouri, United States and 1 other location
Clinical trials
Research sites
Resources
Legal